Editorial: Evidence-Based Medicine-Orthopaedics
In its most distilled definition, evidence-based medicine is a process by which decisions affecting patient care are based on the best medical evidence available at that time. "Best evidence" is information gleaned from a meticulous, conscientious scrutiny of rigorously designed studies. From these primary studies, filtered by systematic reviews (studies with explicit and reproducible methodology in data collection, analysis [statistics] , and application), how we as clinicians collect, interpret, and apply this information is crucial to the evidence based process. Because our clinical decisions profoundly affect the care our patients receive, this is a great responsibility and one we all shoulder with caution, respect, and even reverence.
Is the evidence-based process not what we have been taught from antiquity through the present? Have we not been advised to critically appraise what we are taught, what we read, and how we evaluate and formulate pathways to care? Critical appraisal of scientific (objective) data and information born from laboratory and clinical research, tinctured with a light but essential dose of skepticism, is inscripted on the standard under which we march. Therefore, what does the evidence-based process bring to clinicians and clinical scientists that is new or refreshing or constructive and additive? Why do we do what we do? This appraisal carries within its edict that we must be aware of the least biased and least opinionated information available. How do we become more aware (informed) of those sustaining morsels of reliable, reproducible, and responsible information when the "loaf" of publications is so vast even in our little world of orthopaedics (foot and ankle), which also is a morsel of the "loaf" of medicine? There is only one practical way to effect the evidence-based process in the care of our patients.
We must know the essential and intrinsic elements of the evidence-based process. This we can do.
1. Critical appraisal -the best information from the best sources available. 2. Clinical epidemiology -statistical scrutiny to reduce bias and opinion.
The editorial staff and journals we rely on as clinicians, clinical scientists, and a variety of other care and caregiver pathways are aware of and in tune with the plethora of information and scarcity of time pulling us in varied directions and dividing our attention. Authors, editors and reviewers (referees) are presently aware of the evidence based process and its primary tenets. Our responsibility as clinicians is to bring to the clinical decision table (bedside) the best information available at the time, review the information with the patient, who must ultimately make the decision, and finally apply the indicated and individualized treatment. Of course, the evidence-based process must begin prior to initiation of recommendations and treatments.
To bring the best information available to bear on the treatment of a given patient, we must apprise ourselves of the criteria that define primary studies. These are publications that have the highest levels of evidence available on a given care concern. Primary studies have the most likelihood of the least degree of bias and opinion. These primary studies have incorporated to a higher degree rigorous study design, reliable and responsible methods of collecting information, appropriate statistical interpretation, and specific application consistent with the "results" of the study. With elective care, time is our friend; with emergent care -not so! These "primary studies" will have such terms as 'randomized,' 'prospective,' 'controlled,' 'blinded,' all for the purpose of implying reduced elements of bias and opinion interwoven within the essential components of the study. The probability and even possibility of effecting such studies vary with the intrinsic possibilities and limitations of a given sub-specialty. Consequently, a brief review of the origins and evaluation of the evidence-based process is appropriate.
In 1981, from the Department of Internal Medicine and Clinical Epidemiology at McMaster University, Hamilton, Ontario, Canada, a group of clinicians, concerned that their residents in training were not adequately appraising critically the information used to guide patient care and particularly specific treatment plans and paths, began the application of "critical appraisal," i.e. the best information available at the time is the information which would be brought to the bedside. The term "evidence-based medicine" appeared first in 1990, in an information handout to the incoming internal medicine residents at this same institution and appeared in print for the first time in the American College of Physicians Journal Club in 1991. Desmond Rennie is given credit for coining the term.
Over the following decade other medical and surgical specialties began adopting, modifying, and utilizing the concept of the evidence based process. Why is this history pertinent and relevant to orthopaedic surgeons and particularly to those of us who are specialists in foot and ankle care? To compare and to contrast offers insight into the practicality, possibility, and applicability of the evidence based process to diverse clinical and surgical settings. For the internist, nephrologist, or gastroenterologist a study with 294 EDITORIAL: EVIDENCE-BASED MEDICINE -ORTHOPAEDICS Foot & Ankle International/Vol. 28, No. 3/March 2007 rigor, power, and the elements of randomization, control groups, prospective timing, and blinded investigation is more likely to transpire than for an orthopaedic traumatologist (trauma -a vast portion of orthopaedics and even of the foot and ankle sub-specialty) who is attempting to design and execute a primary study which would withstand scrutiny by the evidence based process (not to mention Institutional Review Boards). To assign patients prospectively and randomly, to reach a power (number of patients with a particular type of fracture, degree of comminution, similar comorbidities, etc.), to have a control group -quickly we see the disparity in the possibility of various medical specialties effecting clinical studies that provide the best evidence and support treatment recommendations. Valid, reliable, reproducible outcome measures and even extended followup required in most orthopaedic research place restraint on bestevidence studies. These are valid caveats. Yet the responsibility remains to have knowledge to critically appraise the studies on which we rely for information and treatment recommendations. Assigning a level of evidence to an article in a peerreview journal is one way to aid the clinician to quickly appraise the strength of a study design. Levels I and II of a therapeutic category paper will be prospective, possibly randomized and blinded, will have control groups, and the data will be statistically appraised for "significance." To know the categories to which studies are assigned also is worthwhile. Papers assessing therapeutic outcomes are the most common in orthopaedic literature. However, diagnostic, prognostic, and economic papers are being published more frequently. Papers of highest levels of evidence are more difficult to construct and effect in the therapeutic category for obvious reasons. However, it is this category of publications that has the most utility for most orthopaedic surgeons. Retrospective studies, particularly with control groups and consecutive case series with strict inclusion and exclusion criteria, similar co-morbidities, limited and well-defined outcome criteria, valid outcome assessment instruments, non-participant patient assessors, and systematic reviews, supporting and clarifying the study can be very helpful to the patient and physician. The introduction, methods, results, and discussion comments of the paper will remain essential elements of the evidence based process for orthopaedic surgeons and with which we are all familiar.
When a level of evidence was assigned to articles in nine orthopaedic journals from January through June of 2003, the difficulties in publishing only the most rigorously designed studies (randomization, prospective timing, control groups, blinded investigation) were obvious. As far as our journal (FAI) was concerned, 20% of the published papers were of Level I or II evidence and over 75% were therapeutic in category. Certainly priority for publication was given to those manuscripts that had the strongest study design and follow through.
Orthopaedic surgeons will continue to rely on mentors, colleagues, "experience," and case series to undergird clinical decision-making, and rightly they should. It is when we bring to a given patient with unique needs and circumstances, within the boundaries of physical, social, economic, and emotional needs and determinants, the most reliable information available, interjected with an admixture of sincerity, compassion, and creativity that we can assuage the stinging indictment by Lewis Thomas, "All medical practice is frivolous and irresponsible. . . a kind of human experimentation based only on trial and error and resulting in precisely that sequence."
Life is short. The art is long. Opportunity is fleeting. Experience is delusive. Judgment is difficult.
-The Aphorisms of Hippocrates EGR/EIC FAI
